Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000070934.69310.1APMID 12771001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men

  2002cited by this paper
• Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study

  2002cited by this paper
• Native LDL Upregulation of ATP‐Binding Cassette Transporter‐1 in Human Vascular Endothelial Cells

  2002cited by this paper
• Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.

  2002cited by this paper
• Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study

  2002cited by this paper
• Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus.

  2002cited by this paper
• Prognostic Value of Coronary Vascular Endothelial Dysfunction

  2002cited by this paper
• High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner*

  2002cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.

  2001cited by this paper
• Distribution and Kinetics of Lipoprotein-Bound Endotoxin

  2001cited by this paper
• Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

  2001cited by this paper
• Cellular regulation of endothelial nitric oxide synthase.

  2001cited by this paper
• Correlation of endothelial function in large and small arteries in human essential hypertension.

  2001cited by this paper
• A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.

  2001cited by this paper
• Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

  2000cited by this paper
• Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

  2000cited by this paper
• Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

  2000cited by this paper
• Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice

  2000cited by this paper
• Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

  2000cited by this paper
• Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

  2000cited by this paper
• A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

  2000cited by this paper
• The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease.

  2000cited by this paper
• High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae*

  2000cited by this paper
• Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.

  2000cited by this paper
• Folic acid reverts dysfunction of endothelial nitric oxide synthase.

  2000cited by this paper
• Malondialdehyde-modified LDL as a marker of acute coronary syndromes.

  1999cited by this paper
• Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

  1999cited by this paper
• Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease.

  1997cited by this paper
• Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

  1996cited by this paper
• Production and Characterization ofa Reconstituted High Density Lipoprotein for Therapeutic Applications

  1996cited by this paper
• Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group.

  1995cited by this paper
• Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

  1995cited by this paper
• Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

  1995cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper

• Exercise Training Enhances Brachial Artery Endothelial Function, Possibly via Improved HDL-C, not LDL-C and TG, in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis

  2025cites this paper
• Multiple facets of HDLs as modifiable risk factors in stroke—the good, the bad, and the ugly

  2025cites this paper
• Lipoprotection in cardiovascular diseases.

  2024cites this paper
• HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy

  2023cites this paper
• ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future

  2022cites this paper
• Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention

  2022cites this paper
• Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy.

  2022cites this paper
• The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions

  2021cites this paper
• A Nomogram to Predict Lifestyle Factors for Recurrence of Large-Vessel Ischemic Stroke

  2021cites this paper
• Cardioprotective role of saliva rosmarinus (rosemary) leaves against oxidative stress and in balancing lipid profile in mice.

  2021cites this paper
• RMHP_A_289761 365..377

  2021cites this paper
• The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease

  2020cites this paper
• The role of intracoronary imaging in translational research.

  2020cites this paper
• No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels.

  2020cites this paper
• Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update

  2020cites this paper
• Relationship Between HDL Functional Characteristics and Cardiovascular Health and Potential Impact of Dietary Patterns: A Narrative Review

  2019cites this paper
• HDL cholesterol and ASCVD risk stratification: A debate.

  2019cites this paper
• Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.

  2019cites this paper
• Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

  2019cites this paper
• Effects of high-density lipoprotein from patients with chronic kidney disease on endothelial function

  2019cites this paper
• Pharmacological inhibition of the F1‐ATPase/P2Y1 pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxation

  2019cites this paper
• Multiomic Signature of Glaucoma Predisposition in Flammer Syndrome Affected Individuals – Innovative Predictive, Preventive and Personalised Strategies in Disease Management

  2019cites this paper
• The High Density Lipoprotein Cholesterol Hypothesis Revisited

  2018cites this paper
• The inverted pattern of circulating miR-221-3p and miR-222-3p associated with isolated low HDL-C phenotype

  2018cites this paper
• Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial

  2018cites this paper
• Patient-Oriented Research

  2017cites this paper
• Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study.

  2017cites this paper
• High‐Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery

  2017cites this paper
• Atheromarkers of high-density lipoproteins. Part 1. High-density lipoproteins: Structure, composition, physicochemical and physiological antiatherogenic properties, their mechanisms and markers (a review of literature)

  2017cites this paper
• Could high-density lipoprotein cholesterol predict increased cardiovascular risk?

  2017cites this paper
• Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia.

  2017cites this paper
• New Insights into the High-Density Lipoprotein Dilemma.

  2016cites this paper
• Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies.

  2016cites this paper
• High-Density Lipoproteins, Endothelial Function, and Mendelian Randomization.

  2016cites this paper
• Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.

  2016cites this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cites this paper
• Dysfunctional HDL and atherosclerotic cardiovascular disease

  2016cites this paper
• Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond

  2016cites this paper
• Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy

  2016cites this paper
• Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM.

  2016cites this paper
• Plasma Metabolic Profile Determination in Young ST-segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra-performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis

  2016cites this paper
• Speciated High-Density Lipoprotein Biogenesis and Functionality

  2016cites this paper
• Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice

  2016cites this paper
• Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy.

  2016cites this paper
• HDL and atherothrombotic vascular disease.

  2015cites this paper
• Dysfunctional HDL: from structure-function-relationships to biomarkers.

  2015cites this paper
• Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques

  2015cites this paper
• Acute high-density lipoprotein therapies

  2015cites this paper
• HDL and atherosclerosis: Insights from inherited HDL disorders.

  2015cites this paper
• HDL re-examined

  2015cites this paper
• Nanomedicines for Endothelial Disorders.

  2015cites this paper
• The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

  2015cites this paper
• The effect of an Apolipoprotein A-I- containing HDL-mimetic Particle (CER-001) on carotid artery wall thickness in Patients with Homozygous Familial Hypercholesterolemia

  2015cites this paper
• ROLE OF ABNORMAL LIPOPROTEINS IN ATHEROSCLEROSIS AND RENAL DISEASE IN LCAT DEFICIENCY

  2014cites this paper
• EVALUATION DE MARQUEURS P ARACLINIQUES DE L'ATHEROSCLEROSE CHEZ DES SUJETS SOUFFRANT D'UN EXCES PONDERAL ET D'UNE DYSLIPIDEMIE. «Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project (peer-reviewed)» Angiology 2008 Aug-Sep;59(4):484-92

  2014cites this paper
• High‐Density Lipoprotein: A Novel Target for Antirestenosis Therapy

  2014cites this paper
• High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.

  2014cites this paper
• CVD in CKD: Focus on the Dyslipidemia Problem

  2014cites this paper
• Anacetrapib: A Potential New Therapy for Dyslipidemia

  2014cites this paper
• Heart Disease and Inflammation

  2014cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• HDL Cholesterol: All Hope Is Not Lost After the Torcetrapib Setback—Emerging Therapeutic Strategies on the Horizon

  2014cites this paper
• Beginning to understand high-density lipoproteins.

  2014cites this paper
• Effect of niacin on endothelial function: A systematic review and meta-analysis of randomized controlled trials

  2014cites this paper
• Almonds inhibit dyslipidemia and vascular dysfunction in rats through multiple pathways.

  2014cites this paper
• Lipid pharmacotherapy for treatment of atherosclerosis

  2014cites this paper
• ATP-binding cassette transporters, atherosclerosis, and inflammation.

  2014cites this paper
• A Closer Look at Cardioprotective Function of HDL: Revise the HDL – Cholesterol Hypothesis?

  2014cites this paper
• Exploring obesity and blood lipids levels in farmers in Eleme local government area, Rivers State of Nigeria.

  2014cites this paper
• eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency

  2014cites this paper
• HDL-Mediated Protection of Coronary Vasodilator Response to Adenosine in the Hypercholesterolemic Swine

  2014cites this paper
• Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.

  2013cites this paper
• Targeting Interferon‐α to the Liver: Apolipoprotein A‐I as a Scaffold for Protein Delivery

  2013cites this paper
• The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.

  2013cites this paper
• HDL-C: clinical equipoise and vascular endothelial function

  2013cites this paper
• High-Density Lipoproteins : Multifunctional but Vulnerable Protections from Atherosclerosis

  2013cites this paper
• Prospects and Future Challenges Translation of High-Density Lipoprotein Function Into Clinical Practice: Current

  2013cites this paper
• Humoral response towards high density lipoprotein : a new mechanism for atherogenesis

  2013cites this paper
• GPR109A and Vascular Inflammation

  2013cites this paper
• High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis.

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) Helium-induced cardioprotection : in sickness and in health , for better or for worse ?

  2013cites this paper
• Imaging progression of coronary atherosclerosis.

  2013cites this paper
• HDL and endothelial protection: examining evidence from HDL inherited disorders

  2013cites this paper
• High-density Lipoprotein–based Therapy Reduces the Hemorrhagic Complications Associated With Tissue Plasminogen Activator Treatment in Experimental Stroke

  2013cites this paper
• Novel strategies to target inflammatory processes in atherosclerosis.

  2013cites this paper
• Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

  2013cites this paper
• Dysfunctional HDL-cholesterol: a potential link between high levels of HDL-cholesterol and cardiovascular disease?

  2013cites this paper
• HDL and endothelial protection

  2013influential citation
• Reconstituted HDL for the acute treatment of acute coronary syndrome

  2013cites this paper
• Glaucomatous Optic Neuropathy: Risk Assessment and Potential Targets for Effective Prevention and Treatments Tailored to the Patient

  2013cites this paper
• High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1

  2013cites this paper
• Helium Induces Preconditioning in Human Endothelium In Vivo

  2013cites this paper
• Reconstituted, Plasma‐Derived High‐Density Lipoprotein

  2012cites this paper
• Low HDL predicts differential blood pressure effects from two weight‐loss approaches: a secondary analysis of blood pressure from a randomized, clinical weight‐loss trial

  2012cites this paper
• Reconstituted HDL in acute coronary syndromes.

  2012cites this paper
• Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk

  2012cites this paper